Purchase Order HHSN269201700535P

The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $20,298.00 on July 20, 2018, with an ultimate completion date of August 1, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines for DNA and RNA analysis supporting NIH research and diagnostic operations. The firm fixed price purchase order represents a...

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $9,947.04 on June 20, 2017, with completion by July 14, 2017. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $19,331.05 on July 5, 2016, with an ultimate completion date of August 17, 2016. No set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price. Specific details regarding the nature of the equipment or consumables procured are not provided in the source material.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $3,500.00 on June 25, 2019, with ultimate completion on September 28, 2020. Place of performance is Bethesda, Maryland. The order carries firm fixed price pricing and no set-aside designation. Specific commodity details are not disclosed in the source.</p>

The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $22,445.10 on June 12, 2019, with an ultimate completion date of September 27, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price for commercial sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core federal portfolio in analytical laboratory instrumentation and in vitro diagnostic substances.

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $18,430.00 on May 30, 2018, with a completion date of June 24, 2019. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was used. The source does not specify the items or services procured under this order.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Illumina, Inc. for $13,250.00, awarded November 15, 2019, with completion by November 17, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside. Specific procurement scope is not detailed in the source.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $4,234.06 on May 30, 2018, with an ultimate completion date of May 30, 2018. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was used.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $10,752.18 on July 3, 2018. The order, placed under firm fixed pricing with no set-aside, calls for sequencing-related products and services. Place of performance is San Diego, California. The order carried an ultimate completion date of July 3, 2018.</p>

<p>NIH Clinical Center awarded a purchase order to Illumina Inc. for $13,120.06 on July 12, 2019, with completion by July 31, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific commodity or service detail is not disclosed in the source; the award follows Illumina's established pattern of supplying sequencing instruments, reagents, consumables, and bioinformatics software to federal health and research agencies.</p>